Provided are a phenylethanoid glycoside extract from the plant A. ilicifolius L., a preparation method thereof, and its use as an anti-liver injury medicament. The preparation method of the phenylethanoid glycoside extract comprises following steps: pulverizing dried whole plant Acanthus ilicifolius L. and passing through 20-30 mesh sieve to obtain Acanthus ilicifolius L. powder, adding 50%-95% ethanol solution whose mass is 8-20 times of the powder, soaking and extracting under reflux, filtering and collecting extract of the powder, and extracting a filter residue under reflux with 50%-95% ethanol solution whose mass is 8-10 times of the filter residue and collecting extract of the filter residue, combining, concentrating and subjecting to macroporous resin column chromatography, eluting successively by 10%, 30% and 50% ethanol solutions for four column volumes, respectively, collecting fraction eluted by the 50% ethanol solution and drying to obtain the phenylethanoid glycoside extract.

The present invention provides a novel sirtuin-1 activating agent, and a formulation for suppressing cell senescence caused by oxidative stress, comprising the agent.

In particular, the invention provides a sirtuin-1 activating agent consisting of a plant body or solvent extract of Peucedanum japonicum Thunb., and a formulation for suppressing cell senescence due to oxidative stress, comprising the agent.

The present invention relates to a novel synergistic herbal formulation for degenerative disease, cardiovascular diseases, autoimmune, inflammatory and infectious diseases and metabolism disorder etc. of man, animal and plants More particularly, the present invention relates to the herbal formulation for degenerative disease, cardiovascular diseases, autoimmune, inflammatory and infectious diseases etc which is prepared by using preparation of pongamia pinnata, Dalbergia sissoo (shishu) and Syzygium aromaticum (clove) which is used as directly and neuro pathways. Moreover this invention relates to the process for the preparation of the above composition.

The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.

The present invention provides use of a soy hull polysaccharide in the preparation of drugs for modulating intestinal flora, reducing blood glucose and blood lipid, and resisting inflammation, and of foods for special medical purpose (FSMPs), and the present invention belongs to the technical field of use of a soy hull polysaccharide. The soy hull polysaccharide provided in the present invention, with an interfacial activity in the intestinal tract, can slow down the absorption of cholesterol or the like; and has the activities for modulating intestinal flora, reducing blood glucose and blood lipid, and preventing intestinal inflammation. The soy hull polysaccharide can be used for preparing drugs for modulating intestinal flora, reducing blood glucose and blood lipid, and preventing and/or treating intestinal inflammation, and for preparing FSMPs.

Provided are methods of reducing and killing bacteria and fungi, and photodynamic treatment methods and sterilization methods using the methods of reducing and killing bacteria and fungi. The method of reducing and killing bacteria and fungi includes bringing a composition including a Ligularia fischeri extract or a fraction thereof as an active ingredient into contact with cells or tissues of a subject and irradiating cells or tissues of a subject in contact with the composition with an absorbable wavelength of excitation light.

This invention relates to the extraction of psychoactive compounds from organisms for use in medicine. Extraction is carried out with a strong acid or strong base to either promote or inhibit dephosphorylation. The extract in the slurry form is standardized with added excipient so that when it is dried the powdered composition has a specified total psychoactive alkaloid concentration, with a known ratio of phosphorylated to dephosphorylated psychoactive alkaloids.

The present disclosure relates generally to new cannabis plants, including parts, extracts and uses thereof, comprising a cannabinoid profile enriched for total CBD (i.e., cannabidiol (CBD) and cannabidiolic acid (CBDA)) and for total THC (i.e., Δ-9-tetrahydrocannabinol (THC) and Δ-9-tetrahydrocannabinolic acid (THCA)).

The present application relates to the production of cannabis products, particularly on a large scale, such as at an industrial level. Cannabis is typically a controlled and regulated substance, and so inventory control, security, and traceability of the cannabis may need to be provided. A human-based manual and/or labour-intensive implementation is not scalable, and is therefore infeasible at an industrial level. Disclosed herein are computer systems for inventory control, security systems, and computer methods for facilitating traceability from a cannabis product back to a batch of cannabis plants.

A method for drying to increase the useful life of botanicals and shorten the time to market after harvest of the botanicals. The method may include flash freezing the botanicals, at a desired optimal temperature range, soon after harvest. The method may include storing the frozen botanicals indefinitely prior to drying. The method may include drying the frozen botanicals using a lyophilizer at a desired optimal temperature and pressure.